8 results on '"Catherine Gooday"'
Search Results
2. Controversies in the management of active Charcot neuroarthropathy
- Author
-
Catherine Gooday, Wendy Hardeman, Fiona Poland, Jim Woodburn, and Ketan Dhatariya
- Subjects
Diseases of the endocrine glands. Clinical endocrinology ,RC648-665 - Abstract
Charcot neuroarthropathy (CN) was first described over 150 years ago. Despite this there remains uncertanity around the factors that contribute to its development, and progression. This article will discuss the current controversies around the pathogenesis, epidemiology, diagnosis, assessment and management of the condition. The exact pathogenesis of CN is not fully understood, and it is likely to be multifactorial, with perhaps currently unknown mechanisms contributing to its development. Further studies are needed to examine opportunities to help screen for and diagnose CN. As a result of many of these factors, the true prevalence of CN is still largely unknown. Almost all of the recommendations for the assessment and treatment of CN are based on low-quality level III and IV evidence. Despite recommendations to offer people with CN nonremovable devices, currently only 40–50% people are treated with this type of device. Evidence is also lacking about the optimal duration of treatment; reported outcomes range from 3 months to more than a year. The reason for this variation is not entirely clear. A lack of standardised definitions for diagnosis, remission and relapse, heterogeneity of populations, different management approaches, monitoring techniques with unknown diagnostic precision and variation in follow-up times prevent meaningful comparison of outcome data. If people can be better supported to manage the emotional and physical consequences of CN, then this could improve people’s quality of life and well-being. Finally, we highlight the need for an internationally coordinated approach to research in CN.
- Published
- 2023
- Full Text
- View/download PDF
3. A randomised feasibility study of serial magnetic resonance imaging to reduce treatment times in Charcot neuroarthropathy in people with diabetes (CADOM)
- Author
-
Catherine Gooday, Frances Game, Jim Woodburn, Fiona Poland, Erika Sims, Ketan Dhatariya, Lee Shepstone, Garry Barton, and Wendy Hardeman
- Subjects
Charcot neuroarthropathy ,Remission ,Diabetes ,MRI ,Temperature monitoring ,X‐ray ,Diseases of the musculoskeletal system ,RC925-935 - Abstract
Abstract Aim This study aims to explore the feasibility of using serial MRI without contrast in the monitoring of Charcot neuroarthropathy to reduce duration of immobilisation of the foot, in order to decide whether a large‐scale trial is warranted. Methods A multicentre, randomised, prospective, two arm, open, feasibility study (CADOM) of people with diabetes with a suspected or confirmed diagnosis of Charcot neuroarthropathy. Participants were randomised (1:1) to ‘standard care plus', including repeated foot temperature measurements and X‐rays, or the intervention arm, with additional three‐monthly MRI, until remission of Charcot neuroarthropathy or a maximum 12 months (active phase). Participants were then followed‐up for a further 6 months, post remission to monitor for relapse of the Charcot neuroarthropathy (follow‐up phase). Feasibility outcomes were recruitment, retention, data completeness, adherence to study procedures and safety of the intervention MRI. We also collected clinical efficacy outcomes, this included time in cast/off‐loading device which will be the primary outcome of a future definitive trial. Finally, we collected patient reported outcomes, and data on health and social care usage. Results One‐hundred and five people were assessed for eligibility at five sites. 64/105 potential participants meet the eligibility criteria to participate in the study. Forty‐three participants were randomised: 20 to standard care plus and 23 to MRI intervention. The main reason for ineligibility was a previous episode of Charcot neuroarthropathy. Thirteen participants were withdrawn post‐randomisation due to an alternative diagnosis being made. Of the remaining 30 participants, 19 achieved remission, 6 had not gone into remission at the end of the 12 month active phase so exited the study. Five participants were lost to follow‐up. Of the MRIs that were not disrupted by COVID‐19 pandemic 26/31 (84%) were completed. For the visits that were conducted face‐to‐face, completion rates of patient‐reported outcome measures were between 71 and 100%. There were no safety incidents associated with the intervention MRI. As this was a feasibility study it was not designed to test the effectiveness of serial MRI in diagnosing remission. The time in cast/off‐loading device was 235 (±108.3) days for the standard care plus arm compared to 292 (±177.4) days for the intervention arm. There was no statistical difference in the time in cast/off‐loading device between the two arms of the study: Hazard Ratio (HR) 0.405 (95% CI 0.140–1.172), p = 0.096. Discussion The findings support a definitive randomised controlled trial to evaluate the effectiveness of MRI in diagnosing remission in Charcot neuroarthropathy. The rates of recruitment, retention, data, and MRI completeness show that a definitive study is feasible. Study registration ISRCTN, 74101606. Registered on 6 November 2017.
- Published
- 2023
- Full Text
- View/download PDF
4. Guidelines on the diagnosis and treatment of active Charcot neuro‐osteoarthropathy in persons with diabetes mellitus (IWGDF 2023)
- Author
-
Dane K. Wukich, Nicolaas C. Schaper, Catherine Gooday, Arun Bal, Robert Bem, Avneesh Chhabra, Mary Hastings, Crystal Holmes, Nina L. Petrova, Maria Gala Santini Araujo, Eric Senneville, and Katherine M. Raspovic
- Subjects
Endocrinology ,Charcot neuro-osteoarthropathy ,Endocrinology, Diabetes and Metabolism ,Charcot foot ,Internal Medicine ,Charcot neuroarthropathy ,guidelines ,Charcot osteoarthropathy ,diabetic foot - Abstract
The International Working Group on the Diabetic Foot (IWGDF) has published evidence-based guidelines on the prevention and management of diabetic foot disease since 1999. This is the first guideline on the diagnosis and treatment of active Charcot neuro-osteoarthropathy in persons with diabetes published by the IWGDF. We followed the GRADE Methodology to devise clinical questions in the PACO (Population, Assessment, Comparison, Outcome) and PICO (Population, Intervention, Comparison, Outcome) format, conducted a systematic review of the medical literature, and developed recommendations with the rationale. The recommendations are based on the evidence from our systematic review, expert opinion when evidence was not available, and also taking into account weighing of the benefits and harms, patient preferences, feasibility and applicability, and costs related to an intervention. We here present the 2023 Guidelines on the diagnosis and treatment of active Charcot neuro-osteoarthropathy in persons with diabetes mellitus and also suggest key future topics of research.
- Published
- 2023
- Full Text
- View/download PDF
5. Diagnosis and treatment of active charcot neuro‐osteoarthropathy in persons with diabetes mellitus: A systematic review
- Author
-
Katherine M. Raspovic, Nicolaas C. Schaper, Catherine Gooday, Arun Bal, Robert Bem, Avneesh Chhabra, Mary Hastings, Crystal Holmes, Nina L. Petrova, Maria Gala Santini Araujo, Eric Senneville, and Dane K. Wukich
- Subjects
Endocrinology ,Endocrinology, Diabetes and Metabolism ,Internal Medicine - Published
- 2023
- Full Text
- View/download PDF
6. Reduction in the prevalence of methicillin‐resistant Staphylococcus aureus in tissue and wound swab samples taken from outpatients attending a specialist diabetic foot clinic 2005–2021
- Author
-
James Moore, Catherine Gooday, Reham Soliman, and Ketan Dhatariya
- Subjects
Endocrinology ,Endocrinology, Diabetes and Metabolism ,Internal Medicine - Published
- 2023
- Full Text
- View/download PDF
7. Guidelines on offloading foot ulcers in persons with diabetes (IWGDF 2023 update)
- Author
-
Sicco A. Bus, David G. Armstrong, Ryan T. Crews, Catherine Gooday, Gustav Jarl, Klaus Kirketerp‐Moller, Vijay Viswanathan, Peter A. Lazzarini, Rehabilitation medicine, and AMS - Rehabilitation & Development
- Subjects
surgery ,Endocrinology ,Endocrinology, Diabetes and Metabolism ,footwear ,offloading ,Internal Medicine ,cast ,diabetic foot ,foot ulcer - Abstract
Aims: Offloading mechanical tissue stress is arguably the most important of multiple interventions needed to heal diabetes-related foot ulcers. This is the 2023 International Working Group on the Diabetic Foot (IWGDF) evidence-based guideline on offloading interventions to promote healing of foot ulcers in persons with diabetes. It serves as an update of the 2019 IWGDF guideline. Materials and Methods: We followed the GRADE approach by devising clinical questions and important outcomes in the PICO (Patient-Intervention-Control-Outcome) format, undertaking a systematic review and meta-analyses, developing summary of judgement tables and writing recommendations and rationales for each question. Each recommendation is based on the evidence found in the systematic review, expert opinion where evidence was not available, and a careful weighing of GRADE summary of judgement items including desirable and undesirable effects, certainty of evidence, patient values, resources required, cost effectiveness, equity, feasibility, and acceptability. Results: For healing a neuropathic plantar forefoot or midfoot ulcer in a person with diabetes, use a non-removable knee-high offloading device as the first-choice offloading intervention. If contraindications or patient intolerance to non-removable offloading exist, consider using a removable knee-high or ankle-high offloading device as the second-choice offloading intervention. If no offloading devices are available, consider using appropriately fitting footwear combined with felted foam as the third-choice offloading intervention. If such a non-surgical offloading treatment fails to heal a plantar forefoot ulcer, consider an Achilles tendon lengthening, metatarsal head resection, joint arthroplasty, or metatarsal osteotomy. For healing a neuropathic plantar or apex lesser digit ulcer secondary to flexibile toe deformity, use digital flexor tendon tenotomy. For healing rearfoot, non-plantar or ulcers complicated with infection or ischaemia, further recommendations have been outlined. All recommendations have been summarised in an offloading clinical pathway to help facilitate the implementation of this guideline into clinical practice. Conclusion: These offloading guideline recommendations should help healthcare professionals provide the best care and outcomes for persons with diabetes-related foot ulcers and reduce the person's risk of infection, hospitalisation and amputation.
- Published
- 2023
- Full Text
- View/download PDF
8. A qualitative study to understand people’s experiences of living with Charcot neuroarthropathy
- Author
-
Catherine Gooday, Wendy Hardeman, Frances Game, Jim Woodburn, and Fiona Poland
- Subjects
Endocrinology ,Depression ,Health Personnel ,Endocrinology, Diabetes and Metabolism ,Diabetes Mellitus ,Internal Medicine ,Humans ,Pain ,Qualitative Research - Abstract
Charcot neuroarthropathy (CN) is a complication of neuropathy, in people with diabetes. Treatment requires the prolonged wearing of an offloading device, which can be challenging. The importance of understanding people's perspectives for promoting their engagement in self management is well known. However, no such studies have been done in CN. This qualitative study aimed to understand people's experiences of CN.Semi-structured interviews with a purposive sample of 14 participants with CN, recruited from a randomised controlled trial. We gathered opinions, thoughts and the meanings participants attributed to their experiences of CN and its physical, socio-economic and physiological effects and how this affected their families and relationships. We analysed the interviews using Inductive Thematic Analysis.Four analytic themes were identified: (1) 'Trapped at home isolated and missing social life and daily life routines'; (2) 'Disruption to people's roles, responsibilities, relationships and mobility, which people adapted to try and address and manage'; (3) 'Pain which participants related to the direct or indirect consequences of wearing the cast or boot'; and (4) 'Blame for developing CN, attributed to themselves and healthcare professionals'. Participants described guilt about needing more support, expressing frustration, low mood and low self-esteem.This study highlights experiential aspects of the previously unrecognised burden of CN. Its physical, social and emotional impacts on participants and their families are substantial and sustained. There is a need to raise clinical awareness of CN and its wider effects.ISRCTN74101606. Registered on 6 November 2017, http://www.isrctn.com/ISRCTN74101606?q=CADomfilters=sort=offset=1totalResults=1page=1pageSize=10searchType=basic-search.
- Published
- 2022
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.